FDA issues statements on VHP sterilization; hip surgery device safety
Editor's Note Recent announcements from The US Food and Drug Administration (FDA) validate vaporized hydrogen peroxide (VHP) as an established device sterilization method and warn against the use of the Synovo Total Hip Replacement system. Issued January 8, the announcement about VHP is part of the agency’s multi-pronged approach to…
Investigation reveals medical device safety testing concerns
Editor's Note Published December 21, a year-long investigation by KFF Health News into medical device malfunctions found that the FDA allows the sale of most medical devices, including many implants, without requiring tests for safety or effectiveness. Instead, manufacturers need to show only that they have “substantial equivalence” to an…
First hospital joins FDA’s medical device information sharing and analysis initiative
Editor’s Note Charlotte, North Carolina-based Atrium Health is the first hospital to join the Medical Device Information Analysis and Sharing (MDIAS) public-private partnership (PPP) between the Food and Drug Administration (FDA) and private sector stakeholders. The news was announced December 12 by Mitre, a nonprofit research organization and the independent…
FDA issues safety notice for syringes made in China
Editor's Note The US Food and Drug Administration (FDA) issued a safety notice on November 30 regarding quality concerns related to several Chinese manufacturers of syringes. The FDA is evaluating these devices for potential problems, including leaks, breakages, and the presence of particles in the syringes. According to the safety…
FDA encourages new cybersecurity standards on medical device manufacturing
Editor's Note The US Food and Drug Administration (FDA) has recognized the latest guidance on medical device cybersecurity from the Association for the Advancement of Medical Instrumentation (AAMI), an AAMI November 14 press release reports. This latest cybersecurity recognition is encouraging its use across the medical device manufacturing industry to…
Steven Rosenberg, pioneer in immunotherapy, awarded National Medal of Technology and Innovation
Editor's Note Steven Rosenberg, MD, PhD, chief of the Surgery Branch at the Center for Cancer Research at the National Cancer Institute, part of the National Institutes of Health (NIH), and a pioneer in the development of immunotherapy to fight cancer, was awarded the National Medal of Technology and Innovation.…
AI brain implants allow paralyzed man to regain use of arms, hands, fingers
Editor's Note In a first of its kind surgical procedure, doctors have installed artificial intelligence (AI) implants in the brain of a 46-year-old man who was paralyzed from a fall on the ice, CNN September 27 reports. The AI implant formed a "digital bridge"–an idea pioneered by the French neuroscientist…
FDA: Class I recall of Mallinckrodt One-Way Valve, 22F x 22M
Editor's Note The Food and Drug Administration (FDA), on September 12, identified the recall by Mallinckrodt Manufacturing of its One-Way Valve, 22F x 22M, as Class I, the most serious. The recall was issued because the devices are not opening properly, which prevents or reduces the flow of ventilated air…
FDA approves updated COVID-19 boosters
Editor's Note The Food and Drug Administration (FDA), on September 11, approved the Moderna and Pfizer/BioNTech updated COVID-19 boosters that target the Omicron subvariant XBB.1.5, the September 11 Reuters reports. The boosters, which were approved for those 12 years and older and authorized for emergency use for children ages 6…
FDA: Class I recall of Cardiosave Hybrid, Rescue IABPs
Editor's Note The Food and Drug Administration (FDA), on August 31, identified the recall by Getinge/Maquet/Datasocpe of its Cardiosave Hybrid and Rescue Intra-aortic Balloon Pumps (IABPs) as Class I, the most serious. The FDA posted four recalls for four separate reasons: Because they may overheat when the device’s internal temperature…
Free Daily News
- GLP-1 drugs reshape surgery demand, threaten hospital revenue
- OR Manager Conference 2025 agenda announced
- Study: No significant link between GLP-1 drugs, postoperative aspiration pneumonia
- Man survives 100 days with artificial titanium heart, setting new milestone
- Study: Sleep-deprived nurses face higher infection risk
- Survey: Health system CEOs prioritize regulation, workforce, technology investments
- 2025 OR Manager Conference unveils next-level leadership strategies for ASCs and beyond
- UnitedHealth’s dominant growth forges ahead amid intensifying antitrust scrutiny
- Analysis: How the new US malpractice standard puts evidence-based ‘reasonable care’ over customary practice
- Healthgrades announces 2025 Patient Safety Excellence Award recipients